MedDataX Logo

CoV-ICU Score, Intensive Care Unit, SARS-CoV-2

NCT ID: NCT04383483

Last Updated: 2021-03-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-06-15

Study Completion Date

2022-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In the course of COVID disease, some patients need intensive care treatment. We aim to find an answer to the question of whether the patient's CRP, ferritin, D-dimer, Oxygen Saturation, lymphocyte count, and body mass index can be used as a criterion for admitting patients with COVID to the intensive see unit.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Clinical Characteristics of Critically Ill Patients With COVID-19

NCT04413435

Coronavirus Infection Critical Illness Characteristics Disease
COMPLETED

Factors Affecting Mortality in Critical Patients Admitted to Intensive Care Unit Due to Coronavirus Disease 2019

NCT04659876

Covid19 and Mortality
COMPLETED

Clinical Features of Severe Patients With COVID-19

NCT04450017

SARS-CoV2
COMPLETED

Characteristics and Outcomes of Patients With COVID-19 Admitted to the ICU

NCT04378582

SARS-CoV 2 Respiratory Distress Syndrome, Adult Corona Virus Infection +1 more
COMPLETED

"Artificial Intelligence-Based Data Analysis Results and Mortality Prediction in Covid-19 Patients in Intensive Care"

NCT06795880

COVID-19
ACTIVE_NOT_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

It is aimed to determine the patients who are above the threshold value to be determined according to this scoring result. Identifying patients who may need intensive care and following them closely will positively affect patient prognosis.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronavirus as the Cause of Diseases Classified Elsewhere

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CoVID patients admitted to ICU

Patients admitted to the intensive care unit with the diagnosis of COVID

COVICU

Intervention Type OTHER

COVICU

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

COVICU

COVICU

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Patients admitted to the intensive care unit with the diagnosis of COVID

Exclusion Criteria

\<18 years patients
Minimum Eligible Age

18 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Bursa Yuksek Ihtisas Training and Research Hospital

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ali ASAN

Associate professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ali Asan, MD

Role: PRINCIPAL_INVESTIGATOR

Bursa Yuksek Ihtisas Training and Research Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Bursa Yüksek Ihtisas Training and Research Hospital

Bursa, Yildirim, Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ali Asan, MD

Role: CONTACT

[email protected]
+905332401067

Erkan Sayan, MD

Role: CONTACT

[email protected]
+905325972556

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ali Asan, MD

Role: primary

[email protected]
+905332401067

Halil Erkan Sayan, MD

Role: backup

[email protected]
+905325972556

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BYIEAH-202005

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Diagnostic and Prognostic Value of D-Lactate and Scube-1 Levels in Critically Ill Patients
NCT06704438 COMPLETED
Effect of Favipiravir on Mortality in Patients With COVID-19 at a Tertiary Center Intensive Care Unit
NCT04645433 COMPLETED
Clinical Characteristics, Outcomes and Risk Factors for Mortality in Pregnant/Puerperal Women With COVID-19 Admitted to ICU in Turkey: a Multicenter, Retrospective Study From a Middle-income Country.
NCT05930340 COMPLETED
Machine Learning in the ICU: Predicting Mortality in Bloodstream Infections (ICU:Intensive Care Unit)
NCT06167083 COMPLETED
COVID-19 Patients Admitted to the ICU
NCT04816786 UNKNOWN
Scoring Systems covid19
NCT05308524 UNKNOWN
Evaluation of the Fluid Response of SARS-CoV-2 (COVID-19) Patients in Intensive Care; Pleth Variability Index
NCT04373213 UNKNOWN
PREdiction of DIagnosed Covid-19 infecTion in IUC Patients
NCT04327180 COMPLETED
Effects of Neutrophil/Lymphocyte, Platelet/Lymphocyte, CRP/Albumin and Lactate on Mortality in Trauma Patients Admitted to Intensive Care
NCT06667310 COMPLETED
Characteristics and Outcomes of Patients Admitted to Swedish Intensive Care Units for COVID-19
NCT04462393 ACTIVE_NOT_RECRUITING
Intensive Care Unit Risk Score
NCT04661735 RECRUITING
Evaluation of the Clinical Relationship Between Procalcitonin Level and Bacteremia Agent in Intensive Care Unit Patients
NCT06958354 COMPLETED
Experience of an Emergency Intensive Care Unit During COVID-19 Pandemic
NCT04480060 COMPLETED
Serum CD14 and CD88 Mointoring in ICU
NCT02120534 COMPLETED
Outcomes of Patients With COVID-19 in the Intensive Care Unit
NCT04336345 COMPLETED
Interleukine 6 (IL6) Assay for Predicting Failure of Spontaneous Breathing in Patients With COVID-19 Acute Respiratory Distress Syndrome
NCT05330845 TERMINATED NA
Effectiveness of Convalescent Immune Plasma Therapy
NCT04442958 COMPLETED NA
Arterial and End-Tidal CO2 Gradient as a Mortality Predictor in Critical Care Patients
NCT05341258 COMPLETED NA
Physical Rehabilitation in ICU in ARDS Patients With COVID-19
NCT04435080 COMPLETED
Can Novel Oxygenation Indices Guide the Diagnosis of Acute Respiratory Distress Syndrome
NCT06430619 COMPLETED
Clinical, Biological and Histological Pulmonary and Renal Damage Associated With the SARS-CoV-2 Syndrome in Patients Admitted in ICU
NCT04385004 UNKNOWN
The New ICU Prognostic Score APACHE-INf
NCT05955547 UNKNOWN
Diagnostic Value of sTREM-1 and PCT Level as Well as CPIS Score for Ventilator-Associated Pneumonia Among ICU Sepsis Patients
NCT01406951 COMPLETED
Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19
NCT04343898 COMPLETED
The Early Prediction of Sepsis in ICU
NCT05088850 UNKNOWN